Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-16
1998-10-20
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548443, 548444, 548447, 548449, A61K 3140, C07D20982
Patent
active
058246991
ABSTRACT:
This invention provides compounds of formula I having the structure ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are, each, independently, hydrogen, alkyl, alkenyl, alkynyl, alkoxy, aralkoxy, trifluroalkoxy, alkanoyloxy, hydroxy, halo, trifluoromethyl, cyano, amino, mono- or di-alkylamino, alkanamido, or alkanesulfonamido;
REFERENCES:
patent: 4686213 (1987-08-01), Ferdinandi et al.
patent: 4927842 (1990-05-01), Mobilio
Humber et al., Etodolac, a Novel Antiiinflammatory Agent. The Synthesis and Biological Evaluation of Its Metabolites 1988, 31:1712-1719; J. Med. Chem.
Lewis and Kreft, A Review on the Strategies for the Development and Application of New Anti-arthritic Agents, Immunopharmacol. Immunotoxicol., 1995, 17:607-663.
Marcus, Aspirin as Prophalaxis Against Colorectal Cancer, New. Eng. J. Med., 1995, 333:656-657.
Vane et al., The mode of action of anti-inflammatroy drugs, Postgrad. Med. J., 1990, 66(Suppl 4):S2-S17.
Brooks et al., Nonsteroidal Antiinflammatory Drug -Differences and Similarities, 1991, New Eng. J. Med., 324:1716-1725.
Dajani et al., Prevention and Treatment of Ulcers Induced by Nonsteroidal Anti-Inflammatory Drugs: An Update, 1995, J. Physiol. Pharmacol., 46:3-16.
Somasundaram et al., The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis, 1995, Scand J. Gastroenterol, 30:289-299.
Hayllar et al., NSAIDs, Cox-2 inhibitors, and the gut, 1995,Lancet, 346:521-522.
O'Neill et al., Overexpression of Human Prostaglandin G/H Synthase-1 and -2 by Recombinant Vaccina Virus: Inhibition by Nonsteroidal Anti-inflammatory Drugs and Biosynthesis of 15-Hydroxyeicosatetraenoic Acid,1994,Molec. Pharmacol.,45:245-254.
Laneuville et al., Differential Inhibition of Human Prostaglandin Endoperoxide H Synthases-1 and -2 by Nonsteroidal Anti-inflammatory Drugs, 1994, Pharamcol. Exp. Ther., 271:927-934.
Mitchell et al., Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxgenase, 1993, Proc. Natl. Acad. Sci. USA, 90:11693-11697.
Chan et al., Pharmacology of a selective Cyclooxygenase-2 Inhibitor, L-745,337: A Novel Nonsteroidal Anti-inflammatory Agent with an Ulcerogenic Sparing Effect in Rat and Nonhuman Primate Stomach, 1995, J. Pharmacol. Exp. Ther., 274:1531-1537.
Masferrer et al., Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic, 1994, Proc. Natl. Acad. Sci. USA, 91:3228-3232.
Seibert et al., Pharmacological and biochemical demonstration of the role of cyclo oxygenase 2 in inflammation and pain, 1994, Proc. Natl. Acad. Sci. USA, 91:12013-12017.
Glaser et al.,Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1, 1995, Eur. J. Pharmacol., 281:107-111.
Sano et al., Expression of Cyclooxygenase-1 and -2 in Human Colorectal Cancer, 1995, Cancer Res., 55:3785-3789.
Rogers et al., Clinical trial of indomethacin in Alzheimer's disease, 1993, Neurology, 43:1609-1611.
Caggiano Thomas J.
Caufield Craig E.
Failli Amedeo A.
Greenfield Alexander A.
Kreft Anthony F.
American Home Products Corporation
Milowsky Arnold S.
Oswecki Jane C.
Richter Johann
LandOfFree
Carbazole inhibitors of Cox-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbazole inhibitors of Cox-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbazole inhibitors of Cox-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-244772